MARKET

ECOR

ECOR

ELECTROCORE, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.960
+0.210
+4.42%
After Hours: 5.20 +0.24 +4.84% 19:52 09/19 EDT
OPEN
4.860
PREV CLOSE
4.750
HIGH
5.64
LOW
4.675
VOLUME
925.06K
TURNOVER
--
52 WEEK HIGH
15.48
52 WEEK LOW
1.230
MARKET CAP
136.70M
P/E (TTM)
-2.6660
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ECOR and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ECOR News

  • 32 Stocks Moving In Thursday's Mid-Day Session
  • Benzinga.13h ago
  • 52 Biggest Movers From Yesterday
  • Benzinga.20h ago
  • FDX, MDR, PTCT and ROAD among midday movers
  • Seeking Alpha - Article.1d ago
  • SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of electroCore, Inc.
  • GlobeNewswire.6d ago

More

Industry

Medical Equipment, Supplies & Distribution
+0.13%
Healthcare Equipment & Supplies
+0.21%

Hot Stocks

Name
Price
%Change

About ECOR

ElectroCore, Inc., formerly ElectroCore LLC, is a commercial-stage bioelectronic medicine healthcare company. The Company is engaged in developing non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and respiratory fields. The Company's gammaCore is a simple-to-use hand-held device that provides non-invasive dispensing therapy, which stimulates the cervical branch of the vagus nerve. The gammaCore is a non-drug treatment for adults who suffer from episodic cluster and migraine pain. The Company's target is the treatment of primary headaches (migraine and cluster headache), and the associated chronic co-morbidities of gastric motility, psychiatric, sleep and pain disorders.
More

Webull offers electroCore, Inc. (ECOR) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.